 |
Journal articles
5-HT(2B) receptors are required for serotonin-selective antidepressant actions.
Abstract : The therapeutic effects induced by serotonin-selective reuptake inhibitor (SSRI) antidepressants are initially triggered by blocking the serotonin transporter and rely on long-term adaptations of pre- and post-synaptic receptors. We show here that long-term behavioral and neurogenic SSRI effects are abolished after either genetic or pharmacological inactivation of 5-HT(2B) receptors. Conversely, direct agonist stimulation of 5-HT(2B) receptors induces an SSRI-like response in behavioral and neurogenic assays. Moreover, the observation that (i) this receptor is expressed by raphe serotonergic neurons, (ii) the SSRI-induced increase in hippocampal extracellular serotonin concentration is strongly reduced in the absence of functional 5-HT(2B) receptors and (iii) a selective 5-HT(2B) agonist mimics SSRI responses, supports a positive regulation of serotonergic neurons by 5-HT(2B) receptors. The 5-HT(2B) receptor appears, therefore, to positively modulate serotonergic activity and to be required for the therapeutic actions of SSRIs. Consequently, the 5-HT(2B) receptor should be considered as a new tractable target in the combat against depression.
Cited literature [32 references]
https://www.hal.inserm.fr/inserm-00652573
Contributor : Luc Maroteaux <>
Submitted on : Thursday, June 14, 2012 - 8:33:45 AM
Last modification on : Wednesday, February 24, 2021 - 12:32:02 PM
Long-term archiving on: : Saturday, September 15, 2012 - 2:21:30 AM
Contributor : Luc Maroteaux <>
Submitted on : Thursday, June 14, 2012 - 8:33:45 AM
Last modification on : Wednesday, February 24, 2021 - 12:32:02 PM
Long-term archiving on: : Saturday, September 15, 2012 - 2:21:30 AM
Files
inserm-00652573_edited.pdf
Files produced by the author(s)
- MolPsy_Diaz.pdf Files produced by the author(s)